PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, presenting promising enhancements across many clinical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, far more reputable alternate for therapeutic use, specifica